RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • As User Fee Bill Sails Through House Committee Vote, a Focus on Industry Efforts

    The House Energy and Commerce Committee advanced the Food and Drug Administration (FDA) Reform Act of 2012 , a package of proposals to both fund and reform the agency, by a unanimous vote involving 46 members of the House of Representatives. "The legislation ensures continuation of various FDA programs, including the Prescription Drug User Fee Act and Medical Device User Fee Act , and authorizes new user fee programs, the Generic Drug User Fee Act and Biosimilar...
  • Group: Industry Lobbying Tarnishing FDA Integrity

    The science advocacy group Union of Concerned Scientists (USC) is lambasting what it claims is excessive industry pressure on the US Food and Drug Administration (FDA), and claims the pharmaceutical, medical device and biotechnology sectors spent a combined $700 million between 2009 and 2011 to lobby legislative and executive officials. "Pharmaceuticals companies and related trade groups spent more than $487 million on lobbying over this three-year period, while biotechn...
  • Washington Lobby Groups Fight Attempt to Limit Chimpanzee Research

    • 31 January 2012
    Washington-based lobbyists are launching a counteroffensive against a piece of proposed legislation known as the Great Ape Protection and Cost Savings Act that would ban researchers that use chimpanzees in their research from receiving federal funds, according to The Hill . The proposed legislation has prompted research facilities to hire lobbyists, including one Texas facility that paid roughly $120,000 to a lobbyist to represent their viewpoints. "Because of th...